COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 1175: Articles 11741-11750  | Next

Modeling the influence of vaccine administration on COVID-19 testing strategies
Forde, J., Ciupe, S.
10.1101/2021.10.14.21265035 — Posted: 2021-10-18
Variation at Spike position 142 in SARS-CoV-2 Delta genomes is a technical artifact caused by dropout of a sequencing amplicon
Sanderson, T., Barrett, J. C.
10.1101/2021.10.14.21264847 — Posted: 2021-10-18
The SARS-CoV-2 infection among students in the University of Porto: a cross-sectional study
Meireles, P., Costa, J. P., Novais, M., Miranda, D., Mendes Lopes, M., Severo, M., Barros, H.
10.1101/2021.10.14.21264978 — Posted: 2021-10-18
Differentiating COVID-19 and dengue from other febrile illnesses in co-epidemics: Development and internal validation of COVIDENGUE scores
Gerardin, P., Maillard, O., Bruneau, L., Accot, F., Legrand, F., Poubeau, P., Manaquin, R., Andry, F., Bertolotti, A., Levin, C.
10.1101/2021.10.14.21264897 — Posted: 2021-10-18 Discussion: Onsite
Clinical observation of high-flow nasal cannula (HFNC) with non-rebreather mask (NRM) use on severe or critically ill COVID-19 diabetic patients
Bhuiyan, A. T., Nath, S. D., Das, S., Das, M., Biswas, R., Ahsan, M., Ziad, M. I.-E.-A., Padma, F. K., Dey, R., Alam, A. S., Zehan, F. H., Saha, A.
10.1101/2021.10.13.21264946 — Posted: 2021-10-18
Predicting COVID-19 Vaccine Efficacy from Neutralizing Antibody Levels
Abedi, M. R., Dixon, S., Guyon, T., Hsu, S., Jacobs, A. R., Nair, L., Terbrueggen, R.
10.1101/2021.10.13.21264921 — Posted: 2021-10-18
COVID-19 Likelihood Meter: a machine learning approach to COVID-19 screening for Indonesian health workers
Sonthalia, S., Muharrom, M. A., Sani, L. L., Herlinda, O., Bella, A., Swashtika, D., Hadisoemarto, P., Saminarsih, D., Lutungan, N., Irwanto, A., Taher, A., Greenstein, J. L.
10.1101/2021.10.15.21265021 — Posted: 2021-10-18
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Dreyer, N. A., Reynolds, M. W., Albert, L. M., Brinkley, E., Kwon, T., Mack, C. D., Toovey, S.
10.1101/2021.10.14.21265010 — Posted: 2021-10-18
Agile design and development of a high throughput cobas(R) SARS-CoV-2 RT-PCR diagnostic test
Manohar, C., Sun, J., Schlag, P., Santini, C., Fontecha, M., Lotscher, P., Bier, C., Goepfert, K., Duncan, D., Spier, G., Jarem, D., Kosarikov, D.
10.1101/2021.10.13.21264919 — Posted: 2021-10-18
A Thermostable Cas12b from Brevibacillus Leverages One-pot Detection of SARS-CoV-2 Variants of Concern
Nguyen, L. T., Macaluso, N. C., Pizzano, B. L. M., Cash, M. N., Spacek, J., Karasek, J., Dinglasan, R. R., Salemi, M., Jain, P. K.
10.1101/2021.10.15.21265066 — Posted: 2021-10-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).